Six Years In And The Results For MiYOSMART Lenses Are Looking Good


This week is MIYOPIA AWARENESS WEEK: 23rd—28th  May, 2022. There is simply no better time to focus on your family’s vision needs!

Recently, Hoya Vision Care—a leader in optical technology innovation—released the results of a six-year MiYOSMART Spectacle lens follow-up clinical study.

The results provided strong evidence that the award-winning MiYOSMART spectacle lens with D.I.M.S. Technology demonstrates long-term effectiveness with continued use in slowing down the progression of myopia (near-sightedness) in children.

“This six-year follow-up clinical study on the MiYOSMART spectacle lens, the longest study conducted on a myopia management spectacle lens ever, shows the myopia control effects are sustainable over time which is very exciting news,” said Natalia Vlasak. As Global Head of Medical and Scientific Affairs at HOYA Vision Care, Natalia continued: “This study also answered another key question from eye care professionals, which was about the rebound effect of the lens. We are very pleased that this clinical study proves that there is no rebound effect if lens use is stopped.”

The benefits of the six-year mark findings extend a previous three-year follow-up study1. In addition, they are part of a continuation of a two-year randomised control trial (R.C.T.)2, as published in the British Journal of Ophthalmology.

The future for your child’s eye health and quality of vision is looking bright!

It is state-of-the-art optical technology and findings like these that excited us here at the Optical Superstore. We love sharing SUPER developments, such as the innovative MiYOSMART spectacle lens technology!

Are you interested to know more?

Please get in touch with our trained staff and qualified professionals at any of our 60+ locations Australia-wide and bookings can now easily be made online.


1 Lam CS, Tang WC, Lee PH, et al. Myopia control effect of defocus incorporated multiple segments (DIMS) spectacle lens in Chinese children: results of a 3-year follow-up study. British Journal of Ophthalmology Published Online First: 17 March 2021. doi: 10.1136/bjophthalmol-2020-317664

2 Lam CSY, Tang WC, Tse DY, Lee RPK, Chun RKM, Hasegawa K, Qi H, Hatanaka T, To CH. Defocus Incorporated Multiple Segments (DIMS) spectacle lenses slow myopia progression: a 2-year randomized clinical trial. British Journal of Ophthalmology. Published Online First: 29 May 2019. doi: 10.1136/bjophthalmol-2018-313739